IRIS UniCatt

Scaldaferri, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.762
EU - Europa 7.560
AS - Asia 7.501
SA - Sud America 1.905
AF - Africa 213
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 20
Totale 26.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.405
SG - Singapore 3.499
CN - Cina 1.899
DE - Germania 1.718
BR - Brasile 1.550
IT - Italia 1.457
SE - Svezia 1.380
FR - Francia 598
VN - Vietnam 417
GB - Regno Unito 392
PL - Polonia 356
IE - Irlanda 351
UA - Ucraina 346
IN - India 292
FI - Finlandia 281
ID - Indonesia 278
CA - Canada 193
RU - Federazione Russa 163
TR - Turchia 163
HK - Hong Kong 152
AR - Argentina 133
KR - Corea 121
MX - Messico 116
IR - Iran 113
JP - Giappone 103
BD - Bangladesh 94
ES - Italia 90
NL - Olanda 87
IQ - Iraq 85
ZA - Sudafrica 68
BE - Belgio 58
AT - Austria 54
EC - Ecuador 54
CZ - Repubblica Ceca 35
CO - Colombia 33
AU - Australia 32
PK - Pakistan 32
VE - Venezuela 32
UZ - Uzbekistan 30
PE - Perù 29
CL - Cile 26
SA - Arabia Saudita 26
CI - Costa d'Avorio 24
EG - Egitto 24
MA - Marocco 23
LT - Lituania 22
CH - Svizzera 21
TN - Tunisia 21
IL - Israele 19
RO - Romania 19
PH - Filippine 18
PY - Paraguay 18
BG - Bulgaria 17
JO - Giordania 17
EU - Europa 16
UY - Uruguay 16
PT - Portogallo 15
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 14
NP - Nepal 14
TW - Taiwan 13
AL - Albania 10
DZ - Algeria 10
HU - Ungheria 10
JM - Giamaica 10
KZ - Kazakistan 10
BO - Bolivia 9
KE - Kenya 9
BY - Bielorussia 8
NZ - Nuova Zelanda 8
TH - Thailandia 8
CY - Cipro 7
HR - Croazia 7
SI - Slovenia 7
DK - Danimarca 6
HN - Honduras 6
KG - Kirghizistan 6
NG - Nigeria 6
NO - Norvegia 6
OM - Oman 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
EE - Estonia 5
GR - Grecia 5
MK - Macedonia 5
PA - Panama 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
GH - Ghana 4
KW - Kuwait 4
LB - Libano 4
LK - Sri Lanka 4
MD - Moldavia 4
MY - Malesia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
Totale 25.927
Salva come PNG Salva come JPEG
Città #
Singapore 1.751
Chandler 1.397
Ashburn 949
Beijing 434
Dublin 341
Los Angeles 305
New York 303
Warsaw 295
Rome 283
Jacksonville 240
Jakarta 235
Hefei 233
San Mateo 202
Munich 185
Ann Arbor 170
Boston 170
Milan 170
São Paulo 165
Dallas 158
Wilmington 158
Ho Chi Minh City 149
Nanjing 145
Frankfurt am Main 138
Cattolica 125
Hong Kong 117
Marseille 117
Princeton 115
The Dalles 115
Houston 109
Fairfield 102
Hanoi 99
Seoul 95
Seattle 92
Dearborn 90
Chicago 89
Moscow 88
Woodbridge 88
Helsinki 87
Redwood City 85
Tokyo 76
Nürnberg 71
Turku 71
Izmir 70
London 69
Kent 67
North Bergen 67
Boardman 65
Brooklyn 63
Stockholm 63
Lawrence 62
Montreal 61
Nuremberg 61
Bremen 59
Hangzhou 56
Buffalo 54
Denver 53
Brussels 47
Rio de Janeiro 47
Nanchang 46
Pune 46
Shanghai 45
Atlanta 44
Baghdad 43
Lappeenranta 43
Poplar 43
Toronto 43
Redmond 42
Belo Horizonte 41
Chennai 40
Santa Clara 40
Johannesburg 37
Orem 37
Phoenix 37
Tianjin 37
Düsseldorf 36
Hebei 36
Shenyang 36
Augusta 35
Hyderabad 34
Lancaster 34
Mountain View 33
Cambridge 32
Detroit 32
San Francisco 31
Guangzhou 30
Mexico City 30
Vienna 30
Changsha 29
Kunming 29
Zhengzhou 29
Washington 27
Norwalk 26
Porto Alegre 26
Trieste 26
Curitiba 25
Paris 25
Abidjan 24
Ankara 24
Manchester 23
Naples 23
Totale 12.800
Salva come PNG Salva come JPEG
Nome #
The interpaly between immune system and microbiota in gynecological diseases : a narrative review. 672
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 339
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 291
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 252
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 238
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 223
The role of diet on gut microbiota composition 201
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 199
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 194
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 189
Management of acute dyarrhea: current and future trends 185
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 183
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 180
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 179
The gut barrier: new acquisitions and therapeutic approaches 176
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 175
Assessment of neurological manifestations in hospitalized patients with COVID-19 172
13C-octanoic acid breath test to study gastric emptying time 171
Bacterial flora as a cause or treatment of chronic diarrhea 169
Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers 169
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 168
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 165
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 156
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 154
Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome 151
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 150
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 149
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 148
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 147
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 145
Dietary magnesium: the magic mineral that protects from colon cancer? 144
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 144
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 141
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 140
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 139
Use and indications of cholestyramine and bile acid sequestrants 136
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 135
RECURRENT PREGNANCY LOSS IS ASSSOCIATED TO LEAKY GUT: A NOVEL PATHOGENIC MODEL OF ENDOMETRIUM INFLAMMATION ? 134
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 132
-Extraintestinal manifestations in inflammatory Bowel disease. 131
Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report 131
The gastrointestinal microbiome - functional interference between stomach and intestine 129
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 129
Differential CD133 expression pattern during mouse colon tumorigenesis 128
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 128
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 128
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 128
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study 128
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 127
Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells 126
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 126
Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride 126
European consensus conference on faecal microbiota transplantation in clinical practice 126
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 126
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease 125
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 124
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 124
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients 124
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 122
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 119
Origin of celiac disease: How old are predisposing haplotypes? 119
Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials 119
A novel pathogenic role for microvasculature in inflammatory bowel disease. 118
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 116
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 116
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 116
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 115
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 115
Use and indications of cholestyramine and bile acid sequestrants 114
Commensal Clostridia: leading players in the maintenance of gut homeostasis 113
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 112
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 111
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 111
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 111
Bacillus clausii and gut homeostasis: state of the art and future perspectives 111
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 110
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. 110
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 109
Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study 109
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 108
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease 108
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 107
Pancreatic function assessment 107
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 107
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 107
The current practice of lynch syndrome diagnosis and management in Italy: A qualitative assessment 107
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 106
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 106
Small bowel bacterial overgrowth and type 1 diabetes 105
Dietary magnesium alleviates experimental murine colitis through modulation of gut microbiota 105
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 103
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 103
Gut microbiota and inflammatory bowel disease: an update 103
Can we predict the efficacy of anti-TNF-α agents? 103
Interesting Case of Infliximab IV Type Hypersensitivity 103
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 102
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 102
Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy) 101
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? 100
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 100
Totale 14.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021682 0 0 0 0 0 89 133 24 126 75 202 33
2021/20221.744 120 83 37 101 123 57 26 241 86 190 345 335
2022/20233.959 513 511 297 601 238 467 195 343 455 80 161 98
2023/20242.401 105 537 99 153 100 317 186 94 127 135 264 284
2024/20255.261 103 152 431 155 431 200 313 207 635 589 1.114 931
2025/20268.114 1.922 526 939 1.864 2.459 404 0 0 0 0 0 0
Totale 26.338